Cargando…

VTE Risk assessment – a prognostic Model: BATER Cohort Study of young women

BACKGROUND: Community-based cohort studies are not available that evaluated the predictive power of both clinical and genetic risk factors for venous thromboembolism (VTE). There is, however, clinical need to forecast the likelihood of future occurrence of VTE, at least qualitatively, to support dec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinemann, Lothar AJ, DoMinh, Thai, Assmann, Anita, Schramm, Wolfgang, Schürmann, Rolf, Hilpert, Jan, Spannagl, Michael
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Original Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087887/ https://www.ncbi.nlm.nih.gov/pubmed/15836797 http://dx.doi.org/10.1186/1477-9560-3-5

Ejemplares similares

Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: A community-based cohort study
por: Spannagl, Michael, et al.
Publicado: (2005)

The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study
por: Heinemann, Lothar AJ, et al.
Publicado: (2004)

Colon cancer risk and different HRT formulations: a case-control study
por: Dinger, Jürgen C, et al.
Publicado: (2007)

Breast cancer risk associated with different HRT formulations: a register-based case-control study
por: Dinger, Juergen C, et al.
Publicado: (2006)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

The Menopause Rating Scale (MRS) scale: A methodological review
por: Heinemann, Klaas, et al.
Publicado: (2004)

Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2013)

The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry
por: Agnelli, Giancarlo, et al.
Publicado: (2015)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT‐AF/VTE study
por: Colonna, Paolo, et al.
Publicado: (2020)

VTE in ICU Patients With COVID-19
por: Moll, Matthew, et al.
Publicado: (2020)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

CLOTTING AND COVID-19: IT IS NOT ALWAYS VTE
por: LINK, STEPHANIE L, et al.
Publicado: (2022)

Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome?
por: Babic, Bruna, et al.
Publicado: (2018)

Analysis of Readmissions Due to VTE—Using Hospital Data to Improve VTE Prophylaxis Compliance: A Quality Improvement Project
por: Hussain, Muzamil Hamid, et al.
Publicado: (2023)

Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism
por: Said, Karim
Publicado: (2013)

Recommendations for VTE Prophylaxis in Medically Ill Patients
por: Skeik, Nedaa, et al.
Publicado: (2020)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
por: Samuelson Bannow, Bethany, et al.
Publicado: (2021)

VTE in ICU: Lessons from COVID-19
por: Chu, Xu, et al.
Publicado: (2022)

Extended anticoagulation for VTE: what evidence justifies it?
por: Walia, Anushka, et al.
Publicado: (2023)

The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics
por: Daig, Isolde, et al.
Publicado: (2003)

No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study
por: Delrue, Maxime, et al.
Publicado: (2022)

Using Clinical Vignettes to Evaluate VTE Protocol Adherence
por: Todoric, Krista, et al.
Publicado: (2012)

Multiple Myeloma: Cast Nephropathy, VTE, and Neurologic Complications
por: Sullivan, Ellen, et al.
Publicado: (2013)

VTE Registry: What Can Be Learned from RIETE?
por: Tzoran, Inna, et al.
Publicado: (2014)

Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019)

What’s new in VTE risk and prevention in orthopedic surgery
por: Kahn, Susan R., et al.
Publicado: (2020)

COVID-19 and Risk of VTE in Ethnically Diverse Populations
por: Go, Alan S., et al.
Publicado: (2021)

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer
por: Glassman, Deanna, et al.
Publicado: (2022)

FRI428 VTE And Testosterone Therapy: What Is The Risk?
por: Cheatham, Callie, et al.
Publicado: (2023)

COVID-19 Associated 60-Day Acute VTE Events in Hospitalized Patients Can be Predicted By D-Dimer and Prior VTE but Not By Reticulated Platelets
por: Ashraf, Bilal, et al.
Publicado: (2022)

Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis
por: Coveney, Eamonn I, et al.
Publicado: (2023)

Analgesics use and ESRD in younger age: a case-control study
por: van der Woude, Fokke J, et al.
Publicado: (2007)

Sickle Cell Trait: Is There an Increased VTE Risk in Pregnancy and the Postpartum?
por: Pintova, Sofya, et al.
Publicado: (2013)

Effectiveness of ASA for VTE Prophylaxis in Arthroscopic Rotator Cuff Repair
por: Austin, Luke, et al.
Publicado: (2018)

Review of Therapeutic Options for the Prevention of VTE in Total Joint Arthroplasty
por: Etscheidt, Jordan, et al.
Publicado: (2020)

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
por: Goshua, George, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_el18vte7to1s3b170fh07bjll1